Dr. Robert Quinn is currently professor and chair of the department of orthopaedic surgery at the UT Health Science Center San Antonio. He is director of the Orthopaedic Residency Program, with a specialization in musculoskeletal oncology. Dr. Quinn received his medical degree from Hahnemann University School of Medicine. He completed an orthopaedic residency at the University of Connecticut School of Medicine followed by a fellowship in orthopaedic oncology at Massachusetts General Hospital/Harvard Medical School. He is a current fellow of the American Academy of Orthopaedic Surgeons and certified by the American Board of Orthopaedic Surgeons. Dr. Quinn is a member of several professional societies including the Musculoskeletal Tumor Society, American Orthopaedic Association, Association of Bone and Joint Surgeons, Connective Tissue Oncology Society and the International Society of Limb Salvage.
He is a member of several multidisciplinary research groups including the Children’s Oncology Group, Southwestern Oncology Group, Radiation Oncology Group, American College of Surgeon’s Oncology Group and International Ewing’s Sarcoma Research Forum. Dr. Quinn has numerous publications including peer-reviewed journal articles and textbook chapters including both editions of the American Academy of Orthopaedic Surgeons Orthopaedic Knowledge Update: Musculoskeletal Tumors. He is currently completing a new textbook on bone and soft tissue tumors as a co-editor. Dr. Quinn has served on a number of national committees, including the Chair Fellowship Committee Musculoskeletal Tumor Society, member of the Education Committee Musculoskeletal Tumor Society, member of the AAOS Evidence Based Practice Committee, member of the American Academy of Orthopaedic Surgeons Musculoskeletal Tumors and Diseases Evaluation Committee, member Board of Specialty Societies Fellowship Match Oversight Committee. He is a consultant reviewer for the Journal of Bone and Joint Surgery and Clinical Orthopaedics and Related Research.
Quinn RH, Randall RL, Benevenia J, Berven SH, Raskin KA. Contemporary management of metastatic bone disease: tips and tools of the trade for general practitioners. J Bone Joint Surg Am. 2013 Oct 16;95(20):1887-95. Review. PubMed PMID: 24288805.
Verschraegen CF, Movva S, Ji Y, Schmit B, Quinn RH, Liem B, Bocklage T, Shaheen M. A phase I study of the combination of temsirolimus with irinotecan for metastatic sarcoma. Cancers (Basel). 2013 Apr 11;5(2):418-29. doi:10.3390/cancers5020418. PubMed PMID: 24216984; PubMed Central PMCID: PMC3730334.